Xlife Sciences AG (XLS) — Strategic Asset Allocation Index
Xlife Sciences AG (XLS) has a Strategic Asset Allocation Index of 0.1% as of June 2025. Strategic assets (PP&E of CHF210.81K plus long-term investments of CHF-) total CHF210.81K, measured against net assets of CHF303.42 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Xlife Sciences AG Strategic Asset Allocation Index (2019–2024)
This chart shows how Xlife Sciences AG's Strategic Asset Allocation Index has evolved across 6 annual periods from 2019 to 2024. As of June 2025, the index stands at 0.1%, representing strategic assets of CHF210.81K against net assets of CHF303.42 Million CHF. Explore Xlife Sciences AG (XLS) cash conversion ratio to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Xlife Sciences AG (2019–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Xlife Sciences AG from 2019 to 2024, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of Xlife Sciences AG.
| Year | SAAI | Strategic Assets (CHF) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 0.1% | CHF269.19K | CHF269.19K | CHF- | CHF305.26 Million | ▼ -0.1 pp |
| 2023 | 0.1% | CHF393.67K | CHF393.67K | CHF- | CHF268.17 Million | ▼ -0.1 pp |
| 2022 | 0.2% | CHF535.58K | CHF535.58K | CHF- | CHF235.23 Million | ▼ -0.1 pp |
| 2021 | 0.3% | CHF669.57K | CHF669.57K | CHF- | CHF211.23 Million | ▼ 0.0 pp |
| 2020 | 0.3% | CHF433.41K | CHF433.41K | CHF- | CHF130.17 Million | ▲ +0.1 pp |
| 2019 | 0.3% | CHF270.58K | CHF270.58K | CHF- | CHF97.38 Million | — |